Literature DB >> 14669177

A staged management diabetes foot program versus standard care: a 1-year cost and utilization comparison in a state public hospital system.

Ronald L Horswell1, James A Birke, Charles A Patout.   

Abstract

OBJECTIVE: To determine whether staged management of foot ulcers reduces health care costs and utilization.
DESIGN: Nonrandomized retrospective study using data from 1998-1999 in the Louisiana public hospital system.
SETTING: Louisiana public hospital system. PARTICIPANTS: Forty-five patients with diabetes foot ulcer who received staged management foot care and 169 patients with diabetes foot ulcer who received standard foot care.
INTERVENTIONS: Staged management of foot ulcers consisting of devices to offload pressure; self-care education; and, after healing, custom-fabricated orthoses and footwear, and monitored progressive ambulation. MAIN OUTCOME MEASURES: One-year levels of the number of foot-related inpatient hospitalizations, number of amputation-related hospitalizations, total number of foot-related inpatient days, total charges for foot-related inpatient hospitalizations, all-cause outpatient visits, total charges for all-cause outpatient visits, and combined outpatient and foot-related inpatient charges.
RESULTS: Over the 12-month study period, the staged management group had a lower foot-related hospitalization rate than did the comparison group (.09 admissions per person vs.50 admissions per person, P=.0002); lower foot-related inpatient days (.91d per person vs 3.97d per person, P=.0289); lower foot-related inpatient charges ($1321 per person vs $5411 per person, P=.0151); fewer amputation-related hospitalizations (.04 per person vs.19 per person, P=.0351); fewer emergency department visits (.60 visits per person vs 1.22 visits per person, P=.0043); lower emergency department charges ($104 per person vs $208 per person, P=.0057); and lower total charges ($4776 per person vs $9402 per person, P=.0141). The staged management group had a higher number of outpatient visits (24.91 per person vs 8.04 per person, P<.0001) and higher outpatient charges ($2169 per person vs $1471 per person, P<.0001).
CONCLUSIONS: A staged management diabetes foot program significantly reduced emergency department and hospital utilization and charges in a statewide public hospital system.

Entities:  

Mesh:

Year:  2003        PMID: 14669177     DOI: 10.1016/s0003-9993(03)00477-5

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

1.  A Critical Evaluation of Existing Diabetic Foot Screening Guidelines.

Authors:  Cynthia Formosa; Alfred Gatt; Nachiappan Chockalingam
Journal:  Rev Diabet Stud       Date:  2016-08-10

2.  Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.

Authors:  Caitlin W Hicks; Shalini Selvarajah; Nestoras Mathioudakis; Bruce A Perler; Julie A Freischlag; James H Black; Christopher J Abularrage
Journal:  J Vasc Surg       Date:  2014-06-14       Impact factor: 4.268

3.  Does incorporation of a clinical support template in the electronic medical record improve capture of wound care data in a cohort of veterans with diabetic foot ulcers?

Authors:  Jeanne R Lowe; Gregory J Raugi; Gayle E Reiber; Joanne D Whitney
Journal:  J Wound Ostomy Continence Nurs       Date:  2013 Mar-Apr       Impact factor: 1.741

4.  The cost of managing diabetic foot ulceration in an Irish hospital.

Authors:  D Smith; M J Cullen; J J Nolan
Journal:  Ir J Med Sci       Date:  2004 Apr-Jun       Impact factor: 1.568

Review 5.  A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types.

Authors:  Andrea C Tricco; Elise Cogo; Wanrudee Isaranuwatchai; Paul A Khan; Geetha Sanmugalingham; Jesmin Antony; Jeffrey S Hoch; Sharon E Straus
Journal:  BMC Med       Date:  2015-04-22       Impact factor: 8.775

6.  Hospitalization Costs of Lower Limb Ulcerations and Amputations in Patients with Diabetes in Romania.

Authors:  Diana I Sima; Cosmina I Bondor; Ioan A Vereşiu; Norina A Gâvan; Cristina M Borzan
Journal:  Int J Environ Res Public Health       Date:  2021-02-24       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.